English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | Dec 19, 2025

Nektar reviews mid-stage data after alopecia drug misses main goal

Patient Daily | Dec 19, 2025

Roche’s Genentech partners with Caris Life Sciences on cancer drug discovery

Patient Daily | Dec 19, 2025

Addition Therapy launches with $100M aiming for one-time treatments for rare diseases

Patient Daily | Dec 19, 2025

New chip enables rapid assessment of brain cancer therapy effectiveness

Patient Daily | Dec 19, 2025

UVA study links traumatic brain injury with increased Alzheimer’s risk through impaired lymphatic drainage

Patient Daily | Dec 19, 2025

Penn State researchers find opposing protein actions affect mRNA stability in human cells

Patient Daily | Dec 19, 2025

University of Utah researchers identify gut bacterium linked to reduced weight gain in mice

Patient Daily | Dec 19, 2025

MEA-based graph modeling detects early brain connectivity changes related to autism risk

Trending

+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift

Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks

+ Regulatory
Patient Daily | Apr 9, 2026

Reason Foundation commentator on vaccine liability: 'Exposing vaccine makers to the machinations of trial lawyers will stymie the development of innovative vaccines'

+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'

  • « First
  • «
  • …
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily